AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GILEAD SCIENCES, INC. Director's Dealing 2013

May 10, 2013

29828_dirs_2013-05-10_07c5db26-499b-48a9-b906-528009b86ffa.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2013-05-08

Reporting Person: HILLS CARLA A (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-05-08	Non-Qualified Stock Options (right to buy)	$52.38	A	8442	Acquired	2023-05-08	Common Stock (8442)	Direct
2013-05-08	Restricted Stock Units	$	A	2863	Acquired		Common Stock (2863)	Direct

Footnotes

F1: Options vest quarterly over the first year of service upon the earlier of May 8, 2014, or the day immediately preceding the next regular annual stockholders meeting.

F2: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F3: 100% of the restricted stock units will vest upon the earlier of May 8, 2014, or the day immediately preceding the next regular annual stockholders meeting.